Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
18 Results for "
CCN1
" in MedChemExpress (MCE) Product Catalog:
Products (18)
18 Results for "CCN1" in MCE Product Catalog:
2
2 Cited Publications
Cat. No.: HY-P7842
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: rHuCCN family member 1/Cyr61, Fc; Protein CYR61; CCN family member 1; Cysteine-rich angiogenic inducer 61; Insulin-like growth factor-binding protein 10 ; GIG1; CYR61; CCN1; IGFBP10;
1
1 Cited Publications
Cat. No.: HY-P704010
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: sCCN1; Cyr61; Igfbp10; CCN family member 1; 3CH61; Cellular communication network factor 1; Cysteine-rich angiogenic IGFBP-10; Protein CYR61; inducer 61; Insulin-like growth factor-binding protein 10; IBP-10; IGF-binding protein 10
Cat. No.: HY-RS02110
Target:
Research Areas:
CCN1 Human Pre-designed siRNA Set A contains three designed siRNAs for CCN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS17949
Target:
Research Areas:
Ccn1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccn1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS24420
Target:
Research Areas:
Ccn1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccn1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P990396
Target:
Research Areas:
Cat. No.: HY-P703551
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CCN1; CCNA; Cyclin-A2
Cat. No.: HY-P83591A
Synonyms: CCN1; CCNA; CCNA1; CCNA2; CT146; Cyclin-A; Cyclin-A1; Cyclin-A2
Cat. No.: HY-RS02117
Target:
Research Areas:
CCNA2 Human Pre-designed siRNA Set A contains three designed siRNAs for CCNA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11023
Target:
Research Areas:
PPP3CA Human Pre-designed siRNA Set A contains three designed siRNAs for PPP3CA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P86830
Synonyms: 3CH61 antibody; CCN 1 antibody; CCN family member 1 antibody; CCN1 antibody; CYR 61 antibody; Cyr61 antibody; CYR61 protein antibody; CYR61_HUMAN antibody; Cysteine rich angiogenic inducer 61 antibody; Cysteine rich heparin binding protein 61 antibody; 3CH61 antibody; CCN 1 antibody; CCN family member 1 antibody; CCN1 antibody; CYR 61 antibody; Cyr61 antibody; CYR61 protein antibody; CYR61_HUMAN antibody; Cysteine rich angiogenic inducer 61 antibody; Cysteine rich heparin binding protein 61 antibody; Cysteine-rich angiogenic inducer 61 antibody; GIG 1 antibody; GIG1 antibody; IBP-10 antibody; IGF-binding protein 10 antibody; Igfbp 10 antibody; IGFBP-10 antibody; Igfbp10 antibody; Insulin like growth factor binding protein 10 antibody; Insulin-like growth factor-binding protein 10 antibody; Protein CYR61 antibody; Protein GIG1 antibody;
Cat. No.: HY-RS18168
Target:
Research Areas:
Ccna2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccna2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-184179
CAS No.: 3103984-17-1
Target:
Research Areas:
TEAD degrader-1 is a potent FBXO22-mediated molecular glue degrader of TEAD, with a 24 h DC50 of 1.0 nM. TEAD degrader-1 binds reversibly and covalently to FBXO22 C326, assembles a functional ternary complex, and mediates proteasomal degradation of TEAD. TEAD degrader-1 exhibits high selectivity for the Hippo pathway and specifically downregulates only TEAD and its downstream target proteins. TEAD degrader-1 is applicable to research related to malignant pleural mesothelioma and non-small cell lung cancer [1].
Cat. No.: HY-181537
PROTAC TEAD1/IAP degrader-2 is an IAP-harnessing TEAD1 PROTAC degrader, with a DC50 of 170 nM against TEAD1 in NCI-H2052 cells. PROTAC TEAD1/IAP degrader-2 exhibits moderate antiproliferative activity in Hippo pathway-dependent mesothelioma cells. PROTAC TEAD1/IAP degrader-2 inhibits the expression of CTGF, but with a weaker effect than the TEAD inhibitor VT-107 (HY-134957). PROTAC TEAD1/IAP degrader-2 can be used in mesothelioma-related research [1].
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
